GENEVA, May 9 -- BEIJING MABWORKS BIOTECH CO., LTD (Room 2505, Tower 1, No. 2 South Ronghua Road, Economic-Technological Development AreaDaxing District, Beijing 100176), 北京天广实生物技术股份有限公司 (中国北京市大兴区北京经济技术开发区荣华南路2号院1号楼2505) filed a patent application (PCT/CN2025/117438) for "USE OF ANTI-CD3/CD20 BISPECIFIC ANTIBODY IN PREPARATION OF DRUG FOR TREATING CD20 POSITIVE B-NHL" on Aug 28, 2025. With publication no. WO/2026/091825, the details related to the patent application...